One Step Forward Toward a Surrogate Endpoint for Clinical Trials of Alzheimer's Disease Drugs: The Results of PharmaCog WP5 (European ADNI)

Frisoni, Giovanni; Blin, Olivier; Bordet, Regis

doi:10.3233/JAD-190267

Scientific article

Editorial

English

One Step Forward Toward a Surrogate Endpoint for Clinical Trials of Alzheimer's Disease Drugs: The Results of PharmaCog WP5 (European ADNI)

ContributorsFrisoni, Giovanni; Blin, Olivier; Bordet, Regis

Published inJournal of Alzheimer's Disease, vol. 69, no. 1, p. 1-2

Publication date2019

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de réadaptation et gériatrie

Research groups

Troubles de mémoire et maladie d'Alzeimer (935)

Citation (ISO format)

FRISONI, Giovanni, BLIN, Olivier, BORDET, Regis. One Step Forward Toward a Surrogate Endpoint for Clinical Trials of Alzheimer’s Disease Drugs: The Results of PharmaCog WP5 (European ADNI). In: Journal of Alzheimer’s Disease, 2019, vol. 69, n° 1, p. 1–2. doi: 10.3233/JAD-190267

Article (Published version)

Identifiers

PID : unige:132434
DOI : 10.3233/JAD-190267
PMID : 30958385

Additional URL for this publicationhttps://content.iospress.com/articles/journal-of-alzheimers-disease/jad190267

Journal ISSN1387-2877

254views

0downloads

Creation20/05/2019 16:20:00

First validation20/05/2019 16:20:00

Update time15/03/2023 21:15:36

Status update15/03/2023 21:15:36

Last indexation31/10/2024 18:01:06

Archive ouverte UNIGE

One Step Forward Toward a Surrogate Endpoint for Clinical Trials of Alzheimer's Disease Drugs: The Results of PharmaCog WP5 (European ADNI)

Technical informations